Pro Share Advisors LLC Haemonetics Corp Transaction History

Pro Share Advisors LLC

  • $39.7 Billion
  • Q3 2024

A detailed history of Pro Share Advisors LLC transactions in Haemonetics Corp stock. As of the latest transaction made, Pro Share Advisors LLC holds 11,715 shares of HAE stock, worth $1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,715
Previous 9,116 28.51%
Holding current value
$1 Million
Previous $754,000 24.8%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$72.45 - $91.58 $188,297 - $238,016
2,599 Added 28.51%
11,715 $941,000
Q2 2024

Aug 13, 2024
SELL
$81.24 - $97.37 $192,863 - $231,156
-2,374 Reduced 20.66%
9,116 $754,000
Q1 2024

May 08, 2024
BUY
$71.24 - $85.35 $36,759 - $44,040
516 Added 4.7%
11,490 $980,000
Q4 2023

Feb 14, 2024
BUY
$80.59 - $92.61 $138,453 - $159,103
1,718 Added 18.56%
10,974 $938,000
Q3 2023

Nov 13, 2023
SELL
$82.56 - $93.49 $17,750 - $20,100
-215 Reduced 2.27%
9,256 $829,000
Q2 2023

Aug 10, 2023
BUY
$80.84 - $89.45 $46,078 - $50,986
570 Added 6.4%
9,471 $806,000
Q1 2023

May 11, 2023
SELL
$72.75 - $90.6 $110,434 - $137,530
-1,518 Reduced 14.57%
8,901 $736,000
Q4 2022

Feb 02, 2023
BUY
$73.85 - $86.14 $88,620 - $103,368
1,200 Added 13.02%
10,419 $819,000
Q3 2022

Nov 04, 2022
SELL
$63.3 - $78.66 $8,482 - $10,540
-134 Reduced 1.43%
9,219 $681,000
Q2 2022

Aug 01, 2022
SELL
$49.27 - $66.08 $255,908 - $343,219
-5,194 Reduced 35.7%
9,353 $610,000
Q1 2022

May 10, 2022
SELL
$43.77 - $63.22 $103,691 - $149,768
-2,369 Reduced 14.0%
14,547 $920,000
Q4 2021

Feb 08, 2022
BUY
$49.55 - $74.59 $283,624 - $426,953
5,724 Added 51.14%
16,916 $897,000
Q3 2021

Nov 12, 2021
SELL
$57.6 - $70.59 $437,011 - $535,566
-7,587 Reduced 40.4%
11,192 $790,000
Q2 2021

Aug 13, 2021
BUY
$51.81 - $118.56 $720,884 - $1.65 Million
13,914 Added 286.0%
18,779 $1.25 Million
Q1 2021

May 14, 2021
SELL
$111.01 - $139.48 $2,664 - $3,347
-24 Reduced 0.49%
4,865 $540,000
Q4 2020

Feb 09, 2021
BUY
$88.75 - $119.95 $52,362 - $70,770
590 Added 13.72%
4,889 $581,000
Q3 2020

Nov 13, 2020
BUY
$75.65 - $93.58 $11,423 - $14,130
151 Added 3.64%
4,299 $375,000
Q2 2020

Aug 03, 2020
SELL
$84.96 - $118.91 $134,406 - $188,115
-1,582 Reduced 27.61%
4,148 $371,000
Q1 2020

May 15, 2020
SELL
$74.34 - $121.82 $499,490 - $818,508
-6,719 Reduced 53.97%
5,730 $571,000
Q4 2019

Feb 12, 2020
BUY
$114.37 - $129.46 $182,992 - $207,136
1,600 Added 14.75%
12,449 $1.43 Million
Q3 2019

Nov 12, 2019
BUY
$117.16 - $138.52 $11,716 - $13,852
100 Added 0.93%
10,849 $1.37 Million
Q2 2019

Aug 13, 2019
SELL
$81.74 - $120.34 $88,687 - $130,568
-1,085 Reduced 9.17%
10,749 $1.29 Million
Q1 2019

May 15, 2019
BUY
$83.25 - $102.12 $117,549 - $144,193
1,412 Added 13.55%
11,834 $1.04 Million
Q4 2018

Feb 14, 2019
SELL
$90.66 - $116.63 $183,949 - $236,642
-2,029 Reduced 16.3%
10,422 $1.04 Million
Q3 2018

Nov 14, 2018
SELL
$89.96 - $114.58 $28,157 - $35,863
-313 Reduced 2.45%
12,451 $1.43 Million
Q2 2018

Aug 13, 2018
BUY
$71.53 - $95.75 $204,218 - $273,366
2,855 Added 28.81%
12,764 $1.15 Million
Q1 2018

May 14, 2018
SELL
$60.72 - $74.41 $62,116 - $76,121
-1,023 Reduced 9.36%
9,909 $725,000
Q4 2017

Feb 14, 2018
BUY
$44.96 - $58.99 $227,003 - $297,840
5,049 Added 85.82%
10,932 $635,000
Q3 2017

Nov 13, 2017
SELL
$40.38 - $44.87 $25,197 - $27,998
-624 Reduced 9.59%
5,883 $264,000
Q2 2017

Aug 11, 2017
BUY
N/A
6,507
6,507 $257,000

Others Institutions Holding HAE

# of Institutions
333
Shares Held
54M
Call Options Held
689K
Put Options Held
345K
View Full List

About HAEMONETICS CORP

HAE Quotes by TradingView
  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $4.39B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email